Back
Protagonist Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$103.75
Seasonality Move:
23.28%
7 Day Trial
ALL ACCESS PASS
$
7
Protagonist Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 54% based on the past 9 years of stock performance.
-
Protagonist Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Protagonist Therapeutics, Inc. Stock Undervalued?The current Protagonist Therapeutics, Inc. [PTGX] share price is $103.78. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 54% based on the past 9 years of stock performance.
Protagonist Therapeutics, Inc. Stock Rating
Buy
51
Protagonist Therapeutics, Inc. (PTGX)
is a Buy
Is Protagonist Therapeutics, Inc. overpriced?
-
Protagonist Therapeutics, Inc. has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Protagonist Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
107.84
52-Week Low:
39.60
Prediction Charts
Market Cap:
6.6B
Price in USD:
103.78
Volume:
601.6K
Beta:
1.86
Technical Analysis
SMA50:
90.62
SMA100:
88.46
SMA200:
74.87
52-Wk Change:
115.31%
Stock Predictions
-
Is Protagonist Therapeutics, Inc. stock public?Yes, Protagonist Therapeutics, Inc. is a publicly traded company.
-
What is the Protagonist Therapeutics, Inc. stock quote today?The Protagonist Therapeutics, Inc. stock price is 103.78 USD today.
-
How to buy Protagonist Therapeutics, Inc. stock online?You can buy Protagonist Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 93.28 | 96.75 | 97.08 | 92.61 |
| Mar-17 | 96.70 | 97.23 | 99.31 | 96.43 |
| Mar-18 | 97.04 | 97.09 | 99.50 | 90.58 |
| Mar-19 | 98.45 | 101.68 | 105.69 | 98.35 |
| Mar-20 | 101.47 | 98.87 | 101.80 | 97.83 |
| Mar-23 | 100.00 | 98.54 | 102.06 | 98.15 |
| Mar-24 | 97.16 | 100.39 | 100.98 | 97.16 |
| Mar-25 | 99.42 | 104.31 | 105.00 | 97.16 |
| Mar-26 | 103.25 | 102.17 | 105.69 | 102.01 |
| Mar-27 | 101.27 | 98.97 | 101.92 | 97.89 |
| Mar-30 | 99.04 | 99.87 | 102.76 | 98.08 |
| Mar-31 | 101.23 | 105.40 | 105.99 | 101.06 |
| Apr-1 | 105.51 | 103.67 | 107.84 | 102.70 |
| Apr-2 | 101.59 | 103.78 | 104.31 | 101.59 |
Protagonist Therapeutics, Inc. Earnings
Protagonist Therapeutics, Inc. Earnings Report: Per Share Protagonist Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics, Inc. Forecast Revenue Growth
Protagonist Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $1.69 per share, a decrease next quarter of $0.46 per share, an increase this year of $4.65 per share, and a decrease next year of $3.21 per share.
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.